5.83
-0.01(-0.17%)
Currency In USD
| Previous Close | 5.84 |
| Open | 5.9 |
| Day High | 6.26 |
| Day Low | 5.5 |
| 52-Week High | 19.49 |
| 52-Week Low | 4.16 |
| Volume | 308,809 |
| Average Volume | 70,718 |
| Market Cap | 46.61M |
| PE | -3.64 |
| EPS | -1.6 |
| Moving Average 50 Days | 5.03 |
| Moving Average 200 Days | 7.49 |
| Change | -0.01 |
If you invested $1000 in electroCore, Inc. (ECOR) since IPO date, it would be worth $19.58 as of November 08, 2025 at a share price of $5.83. Whereas If you bought $1000 worth of electroCore, Inc. (ECOR) shares 5 years ago, it would be worth $252.38 as of November 08, 2025 at a share price of $5.83.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025
GlobeNewswire Inc.
Oct 23, 2025 12:11 PM GMT
ROCKAWAY, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the third quarter ended September 30, 2025
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms
GlobeNewswire Inc.
Sep 30, 2025 12:00 PM GMT
ROCKAWAY, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a peer-reviewed study in Frontiers in Neurology demonstrating th
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium
GlobeNewswire Inc.
Sep 29, 2025 12:00 PM GMT
ROCKAWAY, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCore™ Sapphire (nVNS) has been included in a long-term reimbursement poli